 | 
Excellent work, Nice Design http://endlessexpeditions.com/buy-viramune-baikal-pharmacy-com-ddhf viramune xr 400 mg
Drugmaker Retrophin Inc said it offered to buy therest of Transcept Pharmaceuticals shares it does not already ownfor $4 per share, valuing Transcept at about $75 million.Retrophin's offer represents an 11 percent premium toTranscept's closing share price of $3.59 on the Nasdaq onWednesday.
,
Author: - Kirjoittanut: Anonymous, 03/12/2021, |